Form 4: BioDeisx Director Jack Schuler Acquires 200,000 Shares

Director Jack Schuler of BioDeisx Inc. purchased 200,000 shares of common stock at an average price of $1.17.

Summary

• Jack Schuler, a director and 10% owner of BioDeisx Inc., acquired 200,000 shares of common stock.
• The shares were purchased on November 20, 2024, at a weighted average price of $1.17.
• The purchase was made through the Jack W. Schuler Living Trust, of which Mr. Schuler is the sole trustee.
• Following the transaction, Mr. Schuler beneficially owns 31,094,935 shares indirectly through the trust.

Sentiment

Score: 6

Explanation: The document is neutral in sentiment, as it is a standard disclosure of a share purchase by a director. The purchase could be interpreted as a positive sign, but it's not a major event.

Positives

• The purchase by a director and significant shareholder could be seen as a positive signal of confidence in the company's future.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade in their company's stock. It provides transparency into the trading activities of key personnel.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The purchase of shares by a director is a common occurrence and is not unusual in the context of corporate governance.

Stakeholder Impact

• The share purchase could have a minor positive impact on shareholder confidence.

Key Dates

Keywords

BioDeisx, insider trading, share purchase, director, Jack Schuler, common stock, beneficial ownership